Evidence map›Paper›PMID 31119388›Full record

ReviewBioprocess and biosystems engineering2019

Metaheuristic approaches in biopharmaceutical process development data analysis.

Nishanthi Gangadharan, Richard Turner, Ray Field, Stephen G Oliver, Nigel Slater, Duygu Dikicioglu

Open access · hybridAbstract readReview
In one paragraph

Review in Bioprocess and biosystems engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nishanthi GangadharanDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Richard TurnerCell Sciences, Biopharmaceutical Development, Medimmune, Cambridge, UK.
Ray FieldCell Sciences, Biopharmaceutical Development, Medimmune, Cambridge, UK.
Stephen G OliverDepartment of Biochemistry, University of Cambridge, Cambridge, UK.
Nigel SlaterDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Duygu DikiciogluDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK. dd345@cam.ac.uk.ORCID http://orcid.org/0000-0002-3018-4790
University of Cambridge · GBCTI BioPharma (United Kingdom) · GB

Funding

Leverhulme Trust ECF-2016-681MedImmune The Beacon Project
6 · The paper itself

Abstract

There is a growing interest in mining and handling of big data, which has been rapidly accumulating in the repositories of bioprocess industries. Biopharmaceutical industries are no exception; the implementation of advanced process control strategies based on multivariate monitoring techniques in biopharmaceutical production gave rise to the generation of large amounts of data. Real-time measurements of critical quality and performance attributes collected during production can be highly useful to understand and model biopharmaceutical processes. Data mining can facilitate the extraction of meaningful relationships pertaining to these bioprocesses, and predict the performance of future cultures. This review evaluates the suitability of various metaheuristic methods available for data pre-processing, which would involve the handling of missing data, the visualisation of the data, and dimension reduction; and for data processing, which would focus on modelling of the data and the optimisation of these models in the context of biopharmaceutical process development. The advantages and the associated challenges of employing different methodologies in pre-processing and processing of the data are discussed. In light of these evaluations, a summary guideline is proposed for handling and analysis of the data generated in biopharmaceutical process development.

Indexed as

Biological ProductsDrug IndustryHeuristicsModels, TheoreticalDrug DevelopmentHumansBiological ProductsBiopharmaceutical process development dataData modellingInteractive data visualisationMeta-feature selectionMissing data handling

Identifiers

PMID31119388
PMCPMC6675754
OpenAlexW2945448541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.